Product Information
ONFI 2.5 MG/ML SUSPENSION is a brand product labeled by Lundbeck Pharmaceuticals LLC, priced at $12.4830 per ML under NDC 67386031321. Its NADAC has been published 649 times since Jan 22, 2014.
The High Outlier badge above means this manufacturer's average price in the clobazam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/mL
Manufacturer
Lundbeck Pharmaceuticals LLCNDC
67386031321
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOBAZAMApproval Type
New Drug (NDA)
FDA Application
NDA203993On Market Since
12/14/2012
Pharmacological Classes
Price Statistics
The NADAC for ONFI 2.5 MG/ML SUSPENSION has been published 649 times since Jan 22, 2014, and over the history we have for it it has risen 190.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.4830 per ML |
|---|---|
| All-time high | $12.5514 (May 15, 2024) |
| All-time low | $4.2860 (Feb 19, 2014) |
| 52-week high | $12.4905 |
| 52-week low | $12.4722 |
| Median price | $9.2183 |
| Average price | $8.9462 |
| Largest weekly change | +15.0% (Nov 26, 2014) |
| Weeks tracked | 649 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ONFI 2.5 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for ONFI 2.5 MG/ML SUSPENSION, manufactured by Lundbeck Pharmaceuticals LLC, is $12.4830 per ML (NDC 67386031321), effective Jun 24, 2026.
How has the price of ONFI 2.5 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for ONFI 2.5 MG/ML SUSPENSION has risen 190.4%. It has been tracked across 649 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for ONFI 2.5 MG/ML SUSPENSION?
Since Jan 22, 2014, the NADAC for ONFI 2.5 MG/ML SUSPENSION has ranged from a low of $4.2860 (Feb 19, 2014) to a high of $12.5514 (May 15, 2024), with a median of $9.2183 per ML.
Are there cheaper alternatives to ONFI 2.5 MG/ML SUSPENSION?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, CLOBAZAM 2.5 MG/ML SUSPENSION, is $0.1608 per ML — about 99% below ONFI 2.5 MG/ML SUSPENSION.
Who manufactures ONFI 2.5 MG/ML SUSPENSION?
ONFI 2.5 MG/ML SUSPENSION (NDC 67386031321) is labeled by Lundbeck Pharmaceuticals LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification